InvestSMART

Resonance Health Limited (ASX: RHT) - Announcements

- Current share price for RHT : $0.059

ASX company news and announcements for Resonance Health Limited (RHT) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Resonance Health Limited (RHT) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Resonance Health Limited (RHT), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Resonance Health Limited (RHT)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$28 Change of Director's Interest Notice - Simon Panton 1 Dec 2025 6:45PM $0.052 $0.059 risen by 13.46%
$28 Final Director's Interest Notice - Martin Blake 14 Nov 2025 11:38AM $0.049 $0.059 risen by 20.41%
$28 Results of Annual General Meeting 13 Nov 2025 2:11PM $0.051 $0.059 risen by 15.69%
$28 AGM Presentation 13 Nov 2025 11:28AM $0.047 $0.059 risen by 25.53%
$28 Quarterly Activities/Appendix 4C Cash Flow Report 29 Oct 2025 12:17PM $0.054 $0.059 risen by 9.26%
$28 Change of Director's Interest Notice - Mitchell Wells 29 Oct 2025 8:20AM $0.054 $0.059 risen by 9.26%
$28 Notification of cessation of securities - RHT 28 Oct 2025 4:33PM $0.054 $0.059 risen by 9.26%
$28 Application for quotation of securities - RHT 28 Oct 2025 4:19PM $0.054 $0.059 risen by 9.26%
$28 Notice of Annual General Meeting/Proxy Form 14 Oct 2025 7:12PM $0.048 $0.059 risen by 22.92%
$28 Investor Strategy Day Presentation 13 Oct 2025 1:06PM $0.042 $0.059 risen by 40.48%
$28 Initial Director's Interest Notice - Andrew Harrison 2 Oct 2025 3:55PM $0.039 $0.059 risen by 51.28%
$28 Board Changes 1 Oct 2025 8:53AM $0.039 $0.059 risen by 51.28%
$28 AGM Date & Director Nomination Closing Date 25 Sep 2025 8:20AM $0.037 $0.059 risen by 59.46%
$28 Appendix 4G & Corporate Governance Statement 1 Sep 2025 5:49PM $0.036 $0.059 risen by 63.89%
$28 Updated Shareholder Information - Top 20 Holders 1 Sep 2025 5:44PM $0.036 $0.059 risen by 63.89%
$28 FY25 Full Year Results & FY26 Guidance Investor Presentation 29 Aug 2025 10:27AM $0.041 $0.059 risen by 43.90%
$28 FY25 Full Year Results & FY26 Guidance Investor Presentation 29 Aug 2025 10:27AM $0.041 $0.059 risen by 43.90%
$28 Appendix 4E & Full Year Statutory Accounts 29 Aug 2025 10:27AM $0.041 $0.059 risen by 43.90%
$28 Appendix 4E & Full Year Statutory Accounts 29 Aug 2025 10:27AM $0.041 $0.059 risen by 43.90%
$28 FY25 Full Year Results & FY26 Guidance Webinar Details 11 Aug 2025 9:30AM $0.038 $0.059 risen by 55.26%
$28 Application for quotation of securities - RHT 8 Aug 2025 11:06AM $0.038 $0.059 risen by 55.26%
$28 Quarterly Activities/Appendix 4C Cash Flow Report 31 Jul 2025 9:52AM $0.040 $0.059 risen by 47.50%
$28 TrialsWest Expands with New Clinical Trial Site 8 Jul 2025 11:56AM $0.041 $0.059 risen by 43.90%
$28 Change of Director's Interest Notice - Simon Panton 27 Jun 2025 12:11PM $0.037 $0.059 risen by 59.46%
$28 Launch of InvestorHub 10 Jun 2025 11:16AM $0.038 $0.059 risen by 55.26%

26 - 50 of 531 results

Page 2 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.